KPV is an anti-inflammatory peptide that has demonstrated potential in various disease models. It has been most extensively studied in the context of inflammatory bowel disease, where it has shown encouraging results in reducing inflammation. Research also indicates that KPV and other alpha-MSH derivatives may support wound healing by helping to control inflammation, lower the risk of infection, and improve healing outcomes, including cosmetic appearance. These peptides are being investigated for their possible applications in wound care and scar management, particularly following surgical procedures.